---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-075442"
form_type: "8-K"
ticker: "CGTX"
cik: "0001455365"
company_name: "COGNITION THERAPEUTICS INC"
filed_at: "2026-06-18T12:05:18+00:00"
generated_at: "2026-06-18T12:10:20.763362+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Cognition Therapeutics stockholders elect Fletcher and Ricciardi as Class II directors, ratify Ernst & Young as auditor

## Summary
- Aaron Fletcher, Ph.D. elected with 15,093,537 votes for, 680,677 withheld, 34,035,661 broker non-votes.
- Lisa Ricciardi elected with 15,094,238 votes for, 679,976 withheld, 34,035,661 broker non-votes.
- Ratification of Ernst & Young as independent auditor for 2026: 49,039,407 for, 126,951 against, 643,517 abstentions.
- Annual meeting held June 17, 2026; all proposals passed.

## SEC filing metadata
- accession: 0001104659-26-075442
- form_type: 8-K
- ticker: CGTX
- cik: 0001455365
- company_name: COGNITION THERAPEUTICS INC
- filed_at: 2026-06-18T12:05:18+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1455365/000110465926075442/0001104659-26-075442-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1455365/000110465926075442/tm2618236d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-075442
- JSON: https://secwatch.observer/filing/0001104659-26-075442.json
- Plain text: https://secwatch.observer/filing/0001104659-26-075442.txt

## Key facts
- Shareholder Votes
  COGNITION THERAPEUTICS INC shareholders approved Ratification of Independent Registered Public Accountants at the 2026-06-17 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2026-06-17
  source text: The appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the 2026 fiscal year was ratified, as follows: For Against Abstentions Broker Non-Votes 49,039,407 126,951 643,517 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/1455365/000110465926075442/0001104659-26-075442-index.htm
- Shareholder Votes
  COGNITION THERAPEUTICS INC shareholders approved Election of Class II Directors at the 2026-06-17 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2026-06-17
  source text: Each of Aaron Fletcher, Ph.D., and Lisa Ricciardi were elected to the Board of Directors as Class II directors to serve until the Company’s 2029 Annual Meeting of Stockholders and until their successors, if any, are elected or appointed, or their earlier death, resignation, retirement, disqualification or removal as follows: Name For Withheld Broker Non-Votes Aaron Fletcher, Ph.D. 15,093,537 680,677 34,035,661 Lisa Ricciardi 15,094,238 679,976 34,035,661
  evidence_url: https://www.sec.gov/Archives/edgar/data/1455365/000110465926075442/0001104659-26-075442-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.